Similar articles

• Activities of artesunate-based combinations and tafenoquine against Babesia bovis in vitro and Babesia microti in vivo.

  Carvalho LJM, Tuvshintulga B, Nugraha AB, Sivakumar T, Yokoyama N. Carvalho LJM, et al. Parasit Vectors. 2020 Jul 20;13(1):362. doi: 10.1186/s13071-020-04235-7. Parasit Vectors. 2020. PMID: 32690081 Free PMC article.
• Plasma Blood Levels of Tafenoquine following a Single Oral Dosage in BALBc Mice with Acute Babesia microti Infection That Resulted in Rapid Clearance of Microscopically Detectable Parasitemia.

  Mordue DG, Hale SJ, Dennis WE, Vuong CV, Li XM, Yang N, Wormser GP. Mordue DG, et al. Pathogens. 2023 Aug 31;12(9):1113. doi: 10.3390/pathogens12091113. Pathogens. 2023. PMID: 37764921 Free PMC article.
• Failure of an Approximately Six Week Course of Tafenoquine to Completely Eradicate Babesia microti Infection in an Immunocompromised Patient.

  Prasad PJ, Wormser GP. Prasad PJ, et al. Pathogens. 2022 Sep 15;11(9):1051. doi: 10.3390/pathogens11091051. Pathogens. 2022. PMID: 36145484 Free PMC article.
• Investigating disease severity in an animal model of concurrent babesiosis and Lyme disease.

  Bhanot P, Parveen N. Bhanot P, et al. Int J Parasitol. 2019 Feb;49(2):145-151. doi: 10.1016/j.ijpara.2018.06.006. Epub 2018 Oct 24. Int J Parasitol. 2019. PMID: 30367867 Free PMC article. Review.
• Risk and prevention of transfusion-transmitted babesiosis and other tick-borne diseases.

  Cable RG, Leiby DA. Cable RG, et al. Curr Opin Hematol. 2003 Nov;10(6):405-11. doi: 10.1097/00062752-200311000-00002. Curr Opin Hematol. 2003. PMID: 14564169 Review.